Pharmacological effects of Chinese herb aconite (Fuzi) on cardiovascular system

Journal of Traditional Chinese Medicine

Volumn 32, Issue 3, 2012, Pages 308-313

  Zhao, Dandan ^a,b   Wang, Jie ^a   Cui, Yanjing ^a   Wu, Xinfang ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cardiovascular system; Pharmacologic actions; Radix aconiti lateralis praeparata

Indexed keywords

CARDIOTONIC AGENT; FUZI; HERBACEOUS AGENT; UNCLASSIFIED DRUG; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CARDIOVASCULAR AGENT; CHINESE DRUG;

ACONITE; ARTICLE; CARDIOVASCULAR SYSTEM; CHINESE HERB; DRUG MECHANISM; NONHUMAN; ANTIARRHYTHMIC ACTIVITY; ANTICOAGULATION; APOPTOSIS; ARTERY BLOOD FLOW; CHRONOTROPISM; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART RATE; HEART RHYTHM; HEMODYNAMICS; HUMAN; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; VASOCONSTRICTION; ANIMAL; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECT; PATHOPHYSIOLOGY;

ACONITUM; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DRUGS, CHINESE HERBAL; HEMODYNAMICS; HUMANS;

MLCS; MLOWN;

EID: 84873421798     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(13)60030-8     Document Type: Article

References (39)

1. Rao M R. Reaserch on cardiotonic effect of aconite (WU-TOU, FU-ZI). Yao Xue Xue Bao 1966; 13(3): 195-203.
2. Zuo Z, Gu K M, Yang Y C, Tan S J. Research on effect of Chinese herb aconite (FU-ZI) on "faint pulse verging on expiry" pathological cat model. Di Er Jun Yi Da Xue Xue Bao 1982; 1: 19-23.
3. Xu D H, Zhao H F, Xu Y J, et al. Research of the cardiotonic constituent of raw aconite from Sichuan Jiangyou. Zhong Cao Yao 2004; 35(9): 964-966.
4. Konno C, Shirasaki M, Hikino H. Cardioactive principle of Aconitum carmichaeli roots. Planta Medica 1979; 35(2): 150.
5. Chen D H, Lian X T. Research on constituent of Chinese herb aconite. Yao Xue Xue Bao 1982; 17(10): 792-794.
6. Zhou Y P, Liu W H. Comparision of effects and toxicity of aconite (FU-ZI) on cardiovescular system. Zhong Xi Yi Jie He Za Zhi 1984; 4(1): 48-50.
7. Zhang S Z, Wu B W. Study on the inotropic effect by combination of aconitin with kalium ion channel stimulator on rats'heart in vitro. Zhongguo Yao Li Xue Tong Bao 2001; 17(5): 570-572.
8. Zhang J P, Yang W P. Effect of aconite on NO, TNF-α levels in chronic congestive heart failure rats model. Zhejiang Zhong Yi Yao Da Xue Xue Bao 2009; 33(1): 38-40.
9. Huang H G, Zhu B B, Huang B. Effect of aconite decoction on BNP, IL-6 levels in chronic congestive heart failure rats model. Shan Xi Zhong Yi 2009; 30(6): 745-746.
10. 2-induced myocardial apoptosis in rats. Zhongguo Zhong Yi Yao Ke Ji 2010; 17(4): 315-318.
11. Lee YS, Kang YJ, Kim HJ, et al. Higenamine reduces apoptotic cell death by induction of heme oxygenase-1 in rat myocardial ischemia-reperfusion injury. Apoptosis 2006; 11(7): 1091-1100.
12. Luo J, Min S, Wei K, Cao J. Ion channel mechanism and ingredient bases of Shenfu Decoction's cardiac electrophysiological effects. J Ethnopharmacol 2008; 117(3): 439-445.
13. Cao J, Zhang C D, Zhang G X, Zhang Y J, Min S. Protective injured by effect of Shenfu injection on myocardial mitochondria ischemia ⇀ reperfusion in rabbits. Chin Med J (Engl) 2005; 118(6): 505-507.
14. Meng H L, Cao T. Study on the influence of aconite on aorta vascular extracellular matrix of cardiac hypertrophy rat model induced by thyroxine. Ya Tai Chuan Tong Yi Yao 2009; 5(2): 32-34.
15. Zhan H X, Peng C. Influence of combination aconite and ginger on heart failure rats in epinephrine, angiotensin II, aldosterone, and ANP, NT level in plasma. Zhong Yao Yao Li Yu Lin Chuang 2006; 22(2): 12-14.
16. Campian M E, Hardziyenka M, Bruin K, et al. Early infl ammatory response during the development of right ventricular heart failure in a rat model. Eur J Heart Fail 2010; 12(7): 653-658.
17. Grundtman C, Hollan I, Førre O T, Saatvedt K, Mikkelsen K, Lundberg I E. Cardiovascular Disease in Patients With Inflammatory Rheumatic Disease Is Associated With Up-Regulation of Markers of Inflammation in Cardiac Microvessels and Cardiomyocytes. Arthritis Rheum 2010; 62(3): 667-673.
18. Wei C, Nikolaos G. Frangogiannis. The role of inflammatory and fi brogenic pathways in heart failure associated with aging. Heart Fail Rev 2010; 15(5): 415-422.
19. Yang Q Y, Zhao L C. Influnce of tonifying Qi, warming yang and invigorate blood circulation formula on bone marrow stem cells and cardiac function in patients with myocardial infarction. Zhong Xi Yi Jie He Za Zhi 2008; 28(12): 1078-1081.
20. Zhang M, Zhao J. Research on antiarrhythmic active priciple of aconite. Shizhen Guo Yi Guo Yao, 2000; 11(3): 193-197.
21. Wang P D, Ma X M, Zhang H L, et al. Influnce of lappaconitine on electrocardiogram of anesthetized rats and its anti-arrhythmic effect on experimental. Zhongguo Yao Li Xue Tong Bao 1997; 13(3): 263.
22. De Blasi A. Beta-Adrenergic receptors:Structure,Function and regulation. Drugs Exp Clin Res 1990; 16(3): 107-112.
23. Xiang R, Xu J T. Preliminary study on relationship between pharmacological action of Higenamine and β-AR in heart. Zhongguo Yao Li Xue Tong Bao 1995; 11(2): 113-116.
24. Ameri, A. The effects of Aconitum alkaloids on the central nervous system. Prog Neurobiol 1998; 56(2): 211-235.
25. Nip K W, Law L S. Electrocardiogram analysis of 46 cases of aconitine poisoning. J Pract MedTech 2004; 11(2): 1029.
26. Li L W, Qiu Q M, Wu B. Characteristic and signifcance of ECG in the patients with acute aconitine poisoning. Chin J Crit Care Med 2007(3); 27: 124-126.
27. Yim K M, Tse M L, Lau F L. Reversible intraventricular conduction defect in aconitine poisoning. Singapore Med J 2009; 50(8): e302.
28. Singhuber J, Zhu M, Prinz S, Kopp B. Aconitum in Traditional Chinese Medicine - A valuable drug or an unpredictable risk? J Ethnopharmacol 2009; 126(1): 18-30.
29. Huang M H, Hu D B. Report of treatment of 25 patients with cardiac arrhythmia caused by aconitine poisoning using scopolamine. Zhongguo Xin Xue Guan Bing Yan Jiu Za Zhi 2004; 2(1): 34.
30. Gu K M, Zuo Z, Yang Y C, Tan S J. Study of traditional Chinese medicine Aconite-effect on blood pressure and the mechanism. Di Er Jun Yi Da Xue Xue Bao 1982; 1:13-18
31. Chong W S, Lee Y S, Kang Y J, et al. Comparison of Inodilator Effect of Higemanine, YS-49, YS-51,Tetrahydroisoquinoline Analogs, and Dobutamine in the Rat. Korean J Physiol Pharmacol 1998; 2(3): 323-330.
32. Niu C Q, Zhang T X, Xu H Q, Qin X M. Research of vasodilation effect of aconite decoction on the rabbit aorta in vitro. Zhong Yao Yao Li Yu Lin Chuang 2004; 20(4): 23-25.
33. Xu Q Y, Yu L S, Zhang X L, Chen R M, Chen C M. Influence of aconite and evodia on experimental thrombosis and coagulation system. Xi Bei Yao Xue Za Zhi 1990; 5(2): 487-488.
34. Yun-Choi H S, Pyo M K, Park K M, Chang K C, Lee D H. Anti-thrombotic Effects of Higenamine. Planta Med 2001; 67(7): 619-622.
35. Yun-Choi H S, Pyo M K, Park K M, Chang K C, Lee D H. Anti-thrombotic Effects of YS-49 and YS-51-1-naphthylmethyl Analogs of Higenamine. Thromb Res 2001; 104(4): 249-255.
36. Pyo M K, Kim J M, Jin J L, Chang K C, Lee D H, Yun-Choi H S. Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA2 synthesis and aggregation. Thromb Res 2007; 120(1): 81-86.
37. Yun-Choi H S, Pyo M K, Park K M, Chang K C, Lee D H. The Effects of Higenamine on LPS-Induced Experimental Disseminated Intravascular Coagulation (DIC) in Rats. Planta Med 2002; 68(4): 326.
38. Kang Y J, Koo E B, Lee Y S, Yun-Choi H S, Chang K C. Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS-49, in rat vascular smooth muscle and RAW 264.7 macrophages. Br J Pharmacol 1999; 128(2): 357-364.
39. Huang X Q, Tang J, Zhou Q, Lu H P, Wu Y L, Wu W K. Polysaccharide from Fuzi (FPS) prevents hypercholesterolemia in rats. Lipids Health Dis 2010; 28(9): 9.